Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Controlled-release tablet: 333 mg/145 mg, 500 mg
Registered products in the Philippines
5 products registered with the Food and Drug Administration (FDA) Philippines list Sodium valproate + Valproic acid as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products5
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Encorate Chrono 500Sodium Valproate + Valproic Acid | 333 mg/145 mg Controlled Release TabletAlu/Alu Blister Pack x 10's (Box of 50's) | Rx | Sun Pharma Laboratories LimitedIndia | Sun Pharma Philippines, Inc. | DRP-10110 | Apr 23, 2029 | |
Encorate Chrono 500Sodium Valproate + Valproic Acid (as sodium valproate) | 333 mg/145 mg Controlled-Release TabletStrip Foil x 10's (Box of 50's) | Rx | Sun Pharma Laboratories Ltd.India | Sun Pharma Philippines, Inc. | DRP-9908 | Aug 1, 2030 | |
NoneSodium Valproate + Valproic Acid | 333 mg / 145 mg Controlled Release TabletAlu/Alu Blister Pack x 10’s (Box of 50’s) | Rx | Sun Pharma Laboratories LimitedIndia | Ritemed Phils., Inc.Importer: Sun Pharma Philippines, Inc. | DRP-10110-02 | Apr 23, 2029 | |
Valparin XR 500Sodium Valproate + Valproic Acid | 500 mg Controlled-Release TabletAluminum Foil Strip x 10's (Box of 100's) | Rx | Torrent Pharmaceuticals Ltd.India | Torrent Pharma Philippines Inc. | DRP-2768 | Mar 13, 2032 | |
ValprosSodium Valproate + Valproic Acid | 500 mg Controlled-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Intas Pharmaceuticals Ltd.India | UNILAB, Inc. | DR-XY38389 | Aug 19, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Valproate Disodium/Valproic Acid 250 mg Tablet | ₱7.95–₱27.50Reference ₱8.88 | per tablet | DPRI procurement range |
| Valproate Disodium/Valproic Acid 500 mg Film coated tablet | ₱7.20–₱39.60Reference ₱10.75 | per tablet | DPRI procurement range |
| Valproic Acid + Sodium Valproate 500 mg MR Tablet | ₱10.75–₱11.95Reference ₱10.75 | per tablet | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Sodium Valproate + Valproic Acid |
| PNF listing | Oral: 500 mg (333 mg sodium valproate + 145 mg valproic acid) controlled releasetablet |
| PNF listing | Oral: 500 mg (333 mg sodium valproate + 145 mg valproic acid) controlled release tablet |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .